Blph stock price target

Bellerophon Therapeutics Stock Price Forecast, BLPH stock price prediction. Price target in 14 days: 20.741 USD. The best long-term & short-term Bellerophon  BLPH | Complete Bellerophon Therapeutics Inc. stock news by MarketWatch. Bellerophon Therapeutics started at buy with $3 stock price target at Maxim 

Mar 20, 2020 · Bellerophon Therapeutics Inc (NASDAQ:BLPH) has been assigned an average broker rating score of 1.00 (Strong Buy) from the two brokers that provide coverage for the company, Zacks Investment Research reports.Two investment analysts have rated the stock with a strong buy rating. Brokers have set a one year consensus price objective of $36.24 for the company and are forecasting … Bellerophon Therapeutics (NYSE:BLPH) - Bellerophon ... Feb 19, 2020 · Shares of biotherapeutics company Bellerophon Therapeutics Inc (NASDAQ: BLPH) were more than doubling Tuesday following a positive clinical readout from … BLPH - Bellerophon Ther Com Stock Price - Barchart.com Bellerophon Ther Com (BLPH) Bellerophon Ther Com (BLPH) [[ item.lastPrice ]] It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.

Mar 31, 2020 · Stock quote for Bellerophon Therapeutics, Inc. Common Stock Common Stock (BLPH) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.

View Bellerophon Therapeutics, Inc. BLPH investment & stock information. Get the latest Bellerophon Therapeutics, Inc. BLPH detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. BLPH Bellerophon Therapeutics, Inc. Stock Quote BLPH: More Clinical Data Supports Utility of INOpulse, Near-Term Value-Inflection Opportunities Grow Zacks Small Cap Research-15.89% Oct-23-19 08:30AM Bellerophon Presents New Positive Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at CHEST 2019 BLPH Stock Price and Chart — NASDAQ:BLPH — TradingView

Stock quote and company snapshot for BELLEROPHON THERAPEUTICS INC ( BLPH), including profile, stock chart, recent news and events, analyst Price Performance (Last 52 Weeks), +1.74% There may be differences between the Equity Summary Score analyst count and the number of underlying analysts listed.

Apr 03, 2020 · Bellerophon Therapeutics, Inc. (BLPH), a clinical-stage biotherapeutics company, closed its previously announced registered direct offering of 1,275,000 shares of its common stock at a purchase price of $12.00 per share for total gross proceeds of $15.3 million, before deducting placement agent fees and offering expenses. The Case for Further Gains in Denbury Resources (DNR ...

Analysts Set $36.24 Price Target for Bellerophon ...

Bellerophon Therapeutics Inc. [BLPH] stock Initiated by ...

Stock Comparison: Compare Bellerophon Therapeutics, Inc ...

Maxim Group slashes price target on Bellerophon ... 7 days ago · The new note on the price target was released on April 17, 2017, representing the official price target for Bellerophon Therapeutics Inc. stock. Previously, the target price had yet another raise to $5, while H.C. Wainwright analysts kept a Buy rating on BLPH stock. Bellerophon Therapeutics, Inc. (BLPH) Stock Price, Quote ... Bellerophon Therapeutics, Inc. (BLPH), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, announced that it will host an investor conference call and webcast on the INOpulse® inhaled nitric oxide system (iNO) … Bellerophon Therapeutics Inc., BLPH Quick Chart - (NAS ... BLPH - Bellerophon Therapeutics Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. Bellerophon Therapeutics started at buy with $3 stock price target at Maxim Group MarketWatch. Tuesday, September 05, 2017. 08:40 AM ET.

BLPH Price Target and Analyst Ratings (Bellerophon ... Oct 18, 2019 · 2 Wall Street analysts have issued ratings and price targets for Bellerophon Therapeutics in the last 12 months. Their average twelve-month price target is $30.00, suggesting that the stock has a possible upside of 218.13%. The high price target for BLPH is … BLPH Stock Price, Forecast & News (Bellerophon Therapeutics) 2 brokerages have issued 12 month target prices for Bellerophon Therapeutics' shares. Their forecasts range from $30.00 to $30.00. On average, they anticipate Bellerophon Therapeutics' share price to reach $30.00 in the next year. This suggests a possible upside of 191.5% from the stock's current price.